Taiwan, U.S. Device Pact Highlights Differences In Health Care Systems
This article was originally published in PharmAsia News
Taiwan’s newly formed medical device association forms partnership with AdvaMed to work more closely together to promote innovation and competition.
You may also be interested in...
Suzhou-based Innovent Bio becomes the fourth biotech from mainland China to go public in Hong Kong, and its strong first-day performance may have given the seemingly spooked market so far for such companies a shot of confidence.
A rapidly reforming policy and regulatory environment and a growing culture of innovation are encouraging capital and talent to pour into China, making it a question of when, rather than if, the payoffs will come for both consumers and investors.